R. Peacock

发表

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine

G. Porro, S. Müller-lissner, J. Hosie, 1999, BMJ.

A patient based symptom questionnaire for use in irritable bowel syndrome (IBS)

I. Wiklund, S. Fullerton, C. Hawkey, 2000 .

Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs

C. Hawkey, G. Långström, N. Yeomans, 2002, Gut.

non-steroidal anti-inflammatory drugs gastroduodenal lesions in patients taking in the development of Helicobacter pylori Relative contribution of mucosal injury and and

G. Långström, N. Yeomans, C. Hawkey, 2002 .

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials

I. Wiklund, C. Hawkey, E. Mayer, 2001, Alimentary pharmacology & therapeutics.

Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.

I. Wiklund, S. Müller-lissner, J. Hosie, 1998, Italian journal of gastroenterology and hepatology.

An irritable bowel syndrome-specific symptom questionnaire: development and validation.

I. Wiklund, S. Fullerton, C. Hawkey, 2003, Scandinavian journal of gastroenterology.

Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression

A. Axon, P. Moayyedi, A. Walan, 2000, Helicobacter.

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

C. Hawkey, Á. Lanas, Z. Tulassay, 1998, Lancet.

Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease

G. Porro, S. Müller-lissner, J. Hosie, 1999, PharmacoEconomics.

Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug users

Thomson, C. Hawkey, Hawkey, 1998, Alimentary pharmacology & therapeutics.

Failure of Helicobacter pylori eradication to influence site-specific relapse in high risk NSAID users: Results of a large six month double blind randomised controlled clinical trial

C. Hawkey, Á. Lanas, C. Rensburg, 1998 .

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

C. Hawkey, Á. Lanas, Z. Tulassay, 1998, Lancet.